D-0536-2025 Class III

Recalled by Imprimis NJOF, LLC — Ledgewood, NJ

FDA drug recall D-0536-2025 was initiated by Imprimis NJOF, LLC on Jul 9, 2025 and is designated Class III. Reason for recall: Sub-Potent Drug: Subpotent assay results during stability testing. Affected quantity: 2,890 vials.

Recall details

Product Type
Drugs
Report Date
Jul 30, 2025
Initiation Date
Jul 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,890 vials

Product description

Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.

Reason for recall

Sub-Potent Drug: Subpotent assay results during stability testing.

Distribution pattern

Nationwide in the USA

Code information

Lot: 25MAR032, Exp. 07/16/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0536-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0536-2025. Report a data issue: hello@regdatalab.com.